DOI: http://dx.doi.org/10.18203/2349-3933.ijam20214875

Management of COVID-19 patients, with emphasis on limited resource setting: is less optimum?

Prafulla Samant, Siddhi Ghodge, Ajay Sankhe, Heena Ali, Vijaykumar Gawali, Manoj Kisanrao Bhadre, Swati Suyog Mhatre, Pradnya Anil Bhagat, Santosh Sudhakar Pawar, Rajendra Madhavi, Sushil Shashikant Patil

Abstract


Background: There is scarcity of essential medications, medical talent and health care facilities to treat covid-19, at remote places. This study explores various modalities in resource-limited settings for the management of COVID-19 patients.

Methods: We retrospectively analysed data of 266 consecutive discharged and death Covid-19 patients from 26December 2020 to 29May 2021. All patients were admitted and received appropriate supportive care, regular clinical and laboratory monitoring.

Results: Of total 266 patients the mean age of patients was 49.19 (SD 14.1) years and 185 (69.54%) of them were males. 99 (37%) cases were moderate, 83(31%)were severe cases remaining 84 (32%) were mild cases. 16 (6.01%) patients expired and remaining 250 patients were subsequently discharged. Median duration of stay in the hospital was 9 (37) days. Of total 266 admitted patients’ mortality rate was only 6.01%.

Conclusions: We emphasize that even in healthcare facilities with limited resource, poor infrastructure and lack of ICU facilities, clinical observation-based managementt can help to reduce mortality considerably. Unique features of our study include; use of progesterone as an immunomodulator, use of dual antiviral agents, use of age-related lower limit of oxygen saturation.


Keywords


COVID-19, Limited resource, Treatment, Mortality, Minimal oxygen, Progesterone immunomodulator

Full Text:

PDF

References


COVID-19 Clinical management: living guidance. Available at: https://www.who.int/publications/i/ item/WHO-2019-nCoV-clinical-2021-1. Accessed on 20 August 2021.

Burton G, Hodgkin J, Ward J. Respiratory care. Philadelphia: Lippincott; 1997.

COVID-19. Available at: https://www.icmr.gov.in/ pdf/covid/techdoc/COVID_Management_Algorithm_17052021.pdf. Accessed on 20 August 2021.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13.

Soneja M, Kumar R, Bhattacharya B, Meena V, Aggarwal A, Tripathi M, et al. Characteristics and outcomes of 231 COVID-19 cases admitted at a tertiary facility in India: An observational cohort study. J Family Med Prim Care. 2020;9(12):6267.

Baidya D, Kayina C, Haritha D, Soni L, Behera S, Nair P, et al. Epidemiological & clinical characteristics & early outcome of COVID-19 patients in a tertiary care teaching hospital in India: A preliminary analysis. Indian J Med Res. 2020; 152(1):100.

Bhandari S, Singh A, Sharma R, Rankawat G, Banerjee S, Gupta V, et al. Characteristics, treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study. J Assoc Physicians India. 2020;68(6):13-9.

Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152(1):61-9.

Bairwa M, Kumar R, Ajmal M, Bahurupi Y, Kant R. Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study. J Infect Public Health. 2021;14(8):1028-34.

Girardis M, Busani S, Damiani E, Donati A, Rinaldi L, Marudi A, et al. Effect of conservative vs. conventional oxygen therapy on mortality among patients in an intensive care unit: The oxygen-ICU randomized clinical trial. JAMA. 2016;316(15): 1583.

Gattinoni L, Busana M, Giosa L, Macrì MM, Quintel M. Prone positioning in acute respiratory distress syndrome. Semin Respir Crit Care Med. 2019;40(1):94-100.

Schifino G, de Grauw AJ, Daniele F, Comellini V, Fasano L, Pisani L. Effects of prone and lateral position in non-intubated patients with 2019 Novel Coronavirus (COVID-19) pneumonia. Pulmonol. 2021;27(2):167-71.

Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013;100(2):446-54.

Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178(104787):104787.

Polikarpova AV, Levina IS, Sigai NV, Zavarzin IV, Morozov IA, Rubtsov PM, et al. Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors. Steroids. 2019;145:5-18.

Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology. 2020;161(9):45-9.

Progesterone therapy may improve COVID-19 outcomes for men, study finds: Clinical trial suggests injections of female hormone may reduce disease severity in certain male patients. Available at: https://www.sciencedaily.com/releases/2021/ 03/210318141628.htm. Accessed on 20 August 2021.

Zoler ML. Progesterone eases severe COVID-19 in hospitalized men. Available at: https://www. medscape.com/viewarticle/947822. Accessed on 20 August 2021.

Sheehy LM. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surv. 2020;6(2):e19462.

Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a position paper of the italian association of respiratory physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020;90(1):52-9.

Jiandani MP, Agarwal B, Baxi G, Kale S, Pol T, Bhise A, et al. Evidence-based national consensus: recommendations for physiotherapy management in COVID-19 in acute care indian setup. Indian J Crit Care Med. 2020;24(10):905-13

Madan K, Agarwal B, Swaminathan N, Ravindra S, Bhise A, Kale S, et al. Evidence-based national consensus: recommendations for physiotherapy management in COVID-19 in acute care indian setup. Indian J Crit Care Med. 2020;24(10):905-13.

Gray WK, Navaratnam AV, Day J, Babu P, Mackinnon S, Adelaja I, et al. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the getting it right first time programme. Clin Med. 2021;35(100859):100859.

Vlachos S, Wong A, Metaxa V, Canestrini S, Lopez Soto C, Periselneris J, et al. Hospital mortality and resource implications of hospitalization with COVID-19 in London, UK: A prospective cohort study. Crit Care Res Pract. 2021;2021:8832660.

Docherty AB, Mulholland RH, Lone NI, Cheyne CP, De Angelis D, Diaz-Ordaz K, et al. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021;9(7):773-85.

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and Outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81.

Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16(2): e0245772.

Rieg S, von Cube M, Kalbhenn J, Utzolino S, Pernice K, Bechet L, et al. COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany. PLoS One. 2020;15(11):e0242127.

COVID-19 mortality rate rose by 40% in 2nd wave, more deaths among people under 45 years, finds study. Available at: https://www.firstpost.com/ india/covid-19-mortality-rate-rose-by-40-in-2nd-wave-more-deaths-among-people-under-45-years-finds-study-9763471.html. Accessed on 20 August 2021.

Bhargava A, Szpunar SM, Sharma M, Fukushima EA, Hoshi S, Levine M, et al. Clinical features and risk factors for in-hospital mortality from COVID-19 infection at a tertiary care medical center, at the onset of the US COVID-19 pandemic. J Intens Care Med. 2021;36(6):711-8.

Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical characteristics and morbidity associated with Coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA. 2020;3(6):e2012270.

Burton G, Gee G, Hodgkin JE. Respiratory care, a guide to clinical practice. Philadelphia: Lippincott; 1977.